{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:27:24Z","timestamp":1794648444750,"version":"4.9.1"},"reference-count":75,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Iron-deficiency anemia (IDA) affects nearly one-third of women globally, with heavy menstrual bleeding (HMB) being a significant risk factor among those of reproductive age. Despite the substantial burden of HMB-related IDA, patients often face delays in receiving effective treatment. Oral iron is typically used as first-line therapy, despite frequent gastrointestinal side effects and challenges in treatment adherence. This study evaluated the reproductive life span cost-effectiveness of first-line intravenous (IV) vs oral iron therapy for women with HMB and IDA. We developed a Markov model simulating a cohort of women aged 18 to 51 years, comparing first-line treatment with IV iron dextran, IV ferumoxytol, IV iron sucrose, or oral ferrous sulfate. Costs and quality-adjusted life years (QALYs) were estimated from the societal perspective. IV iron dextran was the cost-effective treatment, yielding 19.26 QALYs at a cost of $157\u2009500, compared with 19.10 QALYs at $152\u2009900 for oral ferrous sulfate. The incremental cost-effectiveness ratio for IV iron dextran was $28\u2009600 per QALY. Treatment with IV ferumoxytol and iron sucrose cost $158\u2009300 and $163\u2009500, respectively, and did not provide additional QALY benefit compared with IV iron dextran, which remained the cost-effective treatment across a range of scenarios and sensitivity analyses. Our findings indicate that first-line treatment with IV iron dextran is the cost-effective strategy for managing IDA in women with HMB at commonly accepted willingness-to-pay thresholds. These results support expanding access to IV iron as a first-line option, and highlight the need to reduce treatment delays and insurance-related barriers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018315","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:52:01Z","timestamp":1767880321000},"page":"1508-1517","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Cost-effectiveness of first-line IV vs oral iron for iron-deficiency anemia in women with heavy menstrual bleeding"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9336-4123","authenticated-orcid":false,"given":"Daniel","family":"Wang","sequence":"first","affiliation":[{"name":"1Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2939-5400","authenticated-orcid":false,"given":"Manraj","family":"Sra","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ito","sequence":"additional","affiliation":[{"name":"3Section of Medical Oncology and Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0754-7901","authenticated-orcid":false,"given":"Ding Quan","family":"Ng","sequence":"additional","affiliation":[{"name":"3Section of Medical Oncology and Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7630-9992","authenticated-orcid":false,"given":"Samira","family":"Glaeser-Khan","sequence":"additional","affiliation":[{"name":"1Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Y.","family":"Wang","sequence":"additional","affiliation":[{"name":"4Yale College, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Hirniak","sequence":"additional","affiliation":[{"name":"5School of Pharmacy, Faculty of Science, University of Waterloo, Kitchener, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-3948","authenticated-orcid":false,"given":"Alfred Ian","family":"Lee","sequence":"additional","affiliation":[{"name":"3Section of Medical Oncology and Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-5697","authenticated-orcid":false,"given":"Adam","family":"Cuker","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"7Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1624-4427","authenticated-orcid":false,"given":"George","family":"Goshua","sequence":"additional","affiliation":[{"name":"3Section of Medical Oncology and Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT"},{"name":"8Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"9","key":"2026030916214312600_bib1","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1016\/S2352-3026(23)00160-6","article-title":"Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021","volume":"10","author":"GBD 2021 Anaemia Collaborators","year":"2023","journal-title":"Lancet Haematol"},{"issue":"1","key":"2026030916214312600_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13045-021-01202-2","article-title":"Burden of anemia and its underlying causes in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019","volume":"14","author":"Safiri","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2026030916214312600_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/asheducation-2016.1.236","article-title":"Heavy menstrual bleeding: work-up and management","volume":"2016","author":"James","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"2026030916214312600_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12325-020-01564-y","article-title":"A review of clinical guidelines on the management of iron deficiency and iron-deficiency anemia in women with heavy menstrual bleeding","volume":"38","author":"Mansour","year":"2021","journal-title":"Adv Ther"},{"issue":"suppl 2","key":"2026030916214312600_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ijgo.14950","article-title":"Overview of iron deficiency and iron deficiency anemia in women and girls of reproductive age","volume":"162","author":"Derman","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"2026030916214312600_bib6","doi-asserted-by":"crossref","first-page":"100071","DOI":"10.1016\/j.jeud.2024.100071","article-title":"Abnormal uterine bleeding: the well-known and the hidden face","volume":"6","author":"Leal","year":"2024","journal-title":"J Endometr Uterine Disord"},{"issue":"suppl 2","key":"2026030916214312600_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ijgo.14945","article-title":"Reflections on access to care for heavy menstrual bleeding: past, present, and in times of the COVID-19 pandemic","volume":"162","author":"Henry","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"suppl 2","key":"2026030916214312600_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijgo.14943","article-title":"Heavy menstrual bleeding, iron deficiency, and iron deficiency anemia: framing the issue","volume":"162","author":"Munro","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"2026030916214312600_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ijgo.13180","article-title":"Abnormal uterine bleeding: a well-travelled path to iron deficiency and anemia","volume":"150","author":"Munro","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"issue":"11","key":"2026030916214312600_bib10","doi-asserted-by":"crossref","first-page":"e1775","DOI":"10.1016\/S2214-109X(23)00416-3","article-title":"Prevalence of heavy menstrual bleeding and associations with physical health and wellbeing in low-income and middle-income countries: a multinational cross-sectional study","volume":"11","author":"Sinharoy","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"5","key":"2026030916214312600_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/13625187.2021.1925881","article-title":"The difficult journey to treatment for women suffering from heavy menstrual bleeding: a multi-national survey","volume":"26","author":"da Silva Filho","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"2026030916214312600_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijgo.2014.09.027","article-title":"Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey","volume":"128","author":"Fraser","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"2026030916214312600_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2023.01.017","article-title":"The relationship between heavy menstrual bleeding, iron deficiency, and iron deficiency anemia","volume":"229","author":"Munro","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2026030916214312600_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/07315724.2008.10719709","article-title":"Prevalence of iron deficiency and health-related quality of life among female students","volume":"27","author":"Grondin","year":"2008","journal-title":"J Am Coll Nutr"},{"issue":"suppl 2","key":"2026030916214312600_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ijgo.14949","article-title":"Optimizing diagnosis and treatment of iron deficiency and iron deficiency anemia in women and girls of reproductive age: clinical opinion","volume":"162","author":"Auerbach","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"suppl 2","key":"2026030916214312600_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ijgo.14948","article-title":"Identification of women and girls with iron deficiency in the reproductive years","volume":"162","author":"MacLean","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"2026030916214312600_bib17","first-page":"17455057251321221","article-title":"Iron deficiency anemia in patients with heavy menstrual bleeding: the patients\u2019 perspective from diagnosis to treatment","volume":"21","author":"Akpan","year":"2025","journal-title":"Womens Health"},{"issue":"9","key":"2026030916214312600_bib18","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/ajh.26987","article-title":"Effect of dietary factors and time of day on iron absorption from oral iron supplements in iron deficient women","volume":"98","author":"von Siebenthal","year":"2023","journal-title":"Am J Hematol"},{"issue":"2","key":"2026030916214312600_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/ejh.13892","article-title":"The role of oral iron in the treatment of adults with iron deficiency","volume":"110","author":"Lo","year":"2023","journal-title":"Eur J Haematol"},{"issue":"17","key":"2026030916214312600_bib20","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2015-05-642223","article-title":"Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women","volume":"126","author":"Moretti","year":"2015","journal-title":"Blood"},{"key":"2026030916214312600_bib21","doi-asserted-by":"crossref","first-page":"102286","DOI":"10.1016\/j.eclinm.2023.102286","article-title":"Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled study","volume":"65","author":"von Siebenthal","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"8","key":"2026030916214312600_bib22","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.cgh.2024.03.046","article-title":"AGA clinical practice update on management of iron deficiency anemia: expert review","volume":"22","author":"DeLoughery","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2026030916214312600_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/asheducation-2016.1.57","article-title":"Single-dose intravenous iron for iron deficiency: a new paradigm","volume":"2016","author":"Auerbach","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7","key":"2026030916214312600_bib24","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ajh.27220","article-title":"Expert consensus guidelines: intravenous iron uses, formulations, administration, and management of reactions","volume":"99","author":"Van Doren","year":"2024","journal-title":"Am J Hematol"},{"issue":"suppl 2","key":"2026030916214312600_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ijgo.14952","article-title":"Evidence gaps for the global problem of iron deficiency and iron deficiency anemia in women and girls of reproductive age","volume":"162","author":"Abbott","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"2026030916214312600_bib26","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1016\/S2352-3026(25)00038-9","article-title":"Management of iron deficiency in children, adults, and pregnant individuals: evidence-based and expert consensus recommendations","volume":"12","author":"Benson","year":"2025","journal-title":"Lancet Haematol"},{"issue":"7","key":"2026030916214312600_bib27","first-page":"e65505","article-title":"Intravenous iron versus oral iron administration for the treatment of iron deficiency anemia: a patient-preference study","volume":"16","author":"Ghamri","year":"2024","journal-title":"Cureus"},{"issue":"2","key":"2026030916214312600_bib28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1586\/17474108.4.2.179","article-title":"Health-related quality of life and economic burden of abnormal uterine bleeding","volume":"4","author":"Fraser","year":"2009","journal-title":"Expert Rev Obstet Gynecol"},{"issue":"1","key":"2026030916214312600_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13561-023-00474-3","article-title":"Cost-effectiveness analysis of parenteral iron therapy compared to oral iron supplements in managing iron deficiency anemia among pregnant women","volume":"14","author":"Saha","year":"2024","journal-title":"Health Econ Rev"},{"issue":"10","key":"2026030916214312600_bib30","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/heapol\/czaa110","article-title":"Is IV iron sucrose a cost-effective option for treatment of severe anaemia in pregnancy as compared with oral iron?","volume":"35","author":"Ray","year":"2021","journal-title":"Health Policy Plan"},{"issue":"8","key":"2026030916214312600_bib31","doi-asserted-by":"crossref","first-page":"102254","DOI":"10.1016\/j.rpth.2023.102254","article-title":"Heavy menstrual bleeding in adolescents: a primary issue in primary care","volume":"7","author":"Simoneau","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"7","key":"2026030916214312600_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.medcli.2021.02.006","article-title":"Heavy menstrual bleeding and its detection in clinical practice","volume":"157","author":"Perell\u00f3","year":"2021","journal-title":"Med Clin"},{"issue":"2","key":"2026030916214312600_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5122(92)90003-M","article-title":"The normal menopause transition","volume":"14","author":"McKinlay","year":"1992","journal-title":"Maturitas"},{"issue":"10","key":"2026030916214312600_bib34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"2026030916214312600_bib35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/aje\/kwr356","article-title":"Menstrual bleeding patterns among regularly menstruating women","volume":"175","author":"Dasharathy","year":"2012","journal-title":"Am J Epidemiol"},{"key":"2026030916214312600_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bpobgyn.2016.09.007","article-title":"Iron deficiency and iron deficiency anaemia in women","volume":"40","author":"Percy","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"10","key":"2026030916214312600_bib37","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.2903\/j.efsa.2015.4254","article-title":"Scientific opinion on dietary reference values for iron","volume":"13","author":"EFSA Panel on Dietetic Products Nutrition and Allergies NDA","year":"2015","journal-title":"EFSA J"},{"issue":"10","key":"2026030916214312600_bib38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ajh.22153","article-title":"Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia","volume":"86","author":"Auerbach","year":"2011","journal-title":"Am J Hematol"},{"issue":"9","key":"2026030916214312600_bib39","doi-asserted-by":"crossref","first-page":"E229","DOI":"10.1002\/ajh.25548","article-title":"Single total dose infusion of ferumoxytol (1020 mg in 30 minutes) is an improved method of administration of intravenous iron","volume":"94","author":"Karki","year":"2019","journal-title":"Am J Hematol"},{"issue":"19","key":"2026030916214312600_bib40","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1001\/jama.2015.15572","article-title":"Comparative risk of anaphylactic reactions associated with intravenous iron products","volume":"314","author":"Wang","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"2026030916214312600_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/17474086.2020.1738215","article-title":"Evaluation of the reported rates of hypersensitivity reactions associated with iron dextran and ferric carboxymaltose based on global data from VigiBaseTM and IQVIATM MIDAS\u00ae over a ten-year period from 2008 to 2017","volume":"13","author":"Durup","year":"2020","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"2026030916214312600_bib42","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaip.2020.11.028","article-title":"Safety of intravenous iron following infusion reactions","volume":"9","author":"Stojanovic","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2026030916214312600_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40264-020-01022-2","article-title":"Frequency and associated costs of anaphylaxis- and hypersensitivity-related adverse events for intravenous iron products in the USA: an analysis using the US Food and Drug Administration Adverse Event Reporting System","volume":"44","author":"Trumbo","year":"2021","journal-title":"Drug Saf"},{"issue":"2","key":"2026030916214312600_bib44","doi-asserted-by":"crossref","first-page":"e2308","DOI":"10.1097\/MD.0000000000002308","article-title":"Intravenous versus oral iron for the treatment of anemia in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"Bonovas","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2026030916214312600_bib45","unstructured":"Actuarial Life Table. Social Security Administration. Accessed 27 June 2025. https:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html."},{"issue":"3","key":"2026030916214312600_bib46","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11136-020-02650-y","article-title":"US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples","volume":"30","author":"Jiang","year":"2021","journal-title":"Qual Life Res"},{"issue":"7","key":"2026030916214312600_bib47","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/aogs.12394","article-title":"Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding","volume":"93","author":"Peuranp\u00e4\u00e4","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"7","key":"2026030916214312600_bib48","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ajh.27686","article-title":"Cost-effectiveness of ferritin screening thresholds for iron deficiency in reproductive-age women","volume":"100","author":"Wang","year":"2025","journal-title":"Am J Hematol"},{"key":"2026030916214312600_bib49","unstructured":"Global Burden of Disease Study 2019\n          . (GBD 2019) Data Resources. GHDx. Accessed 4 September 2025. https:\/\/ghdx.healthdata.org\/gbd-2019."},{"issue":"1","key":"2026030916214312600_bib50","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1186\/s12905-023-02652-1","article-title":"Impact of nausea\/vomiting on EQ-5D-5L utility scores in patients taking iron preparations for heavy menstrual bleeding or anemia","volume":"23","author":"Ito","year":"2023","journal-title":"BMC Womens Health"},{"issue":"6","key":"2026030916214312600_bib51","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jaip.2021.01.007","article-title":"A cost-effectiveness analysis of epinephrine autoinjector risk stratification for patients with food allergy-one epinephrine autoinjector or two?","volume":"9","author":"Shaker","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026030916214312600_bib52","unstructured":"MEPS-HC\n          . Data Tools \u2013 Medical Expenditure Panel Survey (MEPS) Household Component (HC). Accessed 27 June 2025. https:\/\/datatools.ahrq.gov\/meps-hc\/."},{"key":"2026030916214312600_bib53","unstructured":"Clinical Laboratory Fee Schedule. CMS. Accessed 27 June 2025. https:\/\/www.cms.gov\/medicare\/payment\/fee-schedules\/clinical-laboratory-fee-schedule-clfs."},{"key":"2026030916214312600_bib54","unstructured":"GoodRx for Healthcare Professionals. GoodRx. Accessed 27 June 2025. https:\/\/www.goodrx.com\/hcp?srsltid=AfmBOop3Vk_b8PvSR4NEEH-9cC3t9Ip8O5xgJaEZfqhUijhwsJhq0hGO."},{"key":"2026030916214312600_bib55","unstructured":"CPI Home. U.S. Bureau of Labor Statistics. Accessed 27 June 2025. https:\/\/www.bls.gov\/cpi\/."},{"issue":"3","key":"2026030916214312600_bib56","doi-asserted-by":"crossref","first-page":"e224488","DOI":"10.1001\/jamanetworkopen.2022.4488","article-title":"Analysis of adverse events and intravenous iron infusion formulations in adults with and without prior infusion reactions","volume":"5","author":"Arastu","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2026030916214312600_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bmjsrh-2023-201895","article-title":"Red blood cell capacity of modern menstrual products: considerations for assessing heavy menstrual bleeding","volume":"50","author":"DeLoughery","year":"2024","journal-title":"BMJ Sex Reprod Health"},{"key":"2026030916214312600_bib58","author":"U.S. Department of Health and Human Services","year":"2022"},{"issue":"1","key":"2026030916214312600_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/M20-1392","article-title":"A health opportunity cost threshold for cost-effectiveness analysis in the United States","volume":"174","author":"Vanness","year":"2021","journal-title":"Ann Intern Med"},{"issue":"9","key":"2026030916214312600_bib60","first-page":"2790","article-title":"Oral iron supplementation: new formulations, old questions","volume":"109","author":"Pantopoulos","year":"2024","journal-title":"Haematologica"},{"issue":"2","key":"2026030916214312600_bib61","doi-asserted-by":"crossref","first-page":"e0117383","DOI":"10.1371\/journal.pone.0117383","article-title":"Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis","volume":"10","author":"Tolkien","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"2026030916214312600_bib62","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1182\/hematology.2023000495","article-title":"IV iron formulations and use in adults","volume":"2023","author":"Van Doren","year":"2023","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"2026030916214312600_bib63","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.ajkd.2005.04.032","article-title":"Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections","volume":"46","author":"Macdougall","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2026030916214312600_bib64","doi-asserted-by":"crossref","first-page":"e586","DOI":"10.1016\/S2214-109X(22)00127-9","article-title":"Sustainable Development Goals for anaemia: 20 years later, where are we now?","volume":"10","author":"Daru","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"9","key":"2026030916214312600_bib65","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1016\/S2352-3026(25)00168-1","article-title":"Cost-effective targets for anaemia reduction in 191 countries: a modelling study","volume":"12","author":"Blythe","year":"2025","journal-title":"Lancet Haematol"},{"issue":"6","key":"2026030916214312600_bib66","doi-asserted-by":"crossref","first-page":"e026186","DOI":"10.1136\/bmjopen-2018-026186","article-title":"Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women","volume":"9","author":"Schoep","year":"2019","journal-title":"BMJ Open"},{"key":"2026030916214312600_bib67","volume-title":"Facility Fees 101: What is all the Fuss About?","year":"2023"},{"key":"2026030916214312600_bib68","unstructured":"Monahan\n              C\n            , DavenportK, SwindleR. Protecting Patients from Unexpected Outpatient Facility Fees: States on the Precipice of Broader Reform. Georgetown University. 2023. Accessed 2 September 2025. https:\/\/chir.georgetown.edu\/publications\/protecting-patients-from-unexpected-outpatient-facility-fees-states-on-the-precipice-of-broader-reform\/."},{"issue":"2","key":"2026030916214312600_bib69","doi-asserted-by":"crossref","first-page":"e2308","DOI":"10.1097\/MD.0000000000002308","article-title":"Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease","volume":"95","author":"Bonovas","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"2026030916214312600_bib70","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/0272989X11401031","article-title":"Catalogue of EQ-5D Scores for the United Kingdom","volume":"31","author":"Sullivan","year":"2011","journal-title":"Med Decis Making"},{"issue":"1","key":"2026030916214312600_bib71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.36469\/jheor.2022.32983","article-title":"Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece","volume":"9","author":"Gourzoulidis","year":"2022","journal-title":"J Health Econ Outcomes Res"},{"key":"2026030916214312600_bib72","unstructured":"Occupational Employment and Wage Statistics (OEWS) Tables\n          . Bureau of Labor Statistics. Accessed 1 September 2025. https:\/\/www.bls.gov\/oes\/tables.htm."},{"key":"2026030916214312600_bib73","unstructured":"Medicare Part B Drug Average Sales Price | CMS. December 23, 2024. Accessed 23 December 2024. https:\/\/www.cms.gov\/medicare\/payment\/fee-for-service-providers\/part-b-drugs\/average-drug-sales-price."},{"key":"2026030916214312600_bib74","unstructured":"Registered Nurses\n          . Bureau of Labor Statistics. Accessed 23 December 2024. https:\/\/www.bls.gov\/oes\/current\/oes291141.htm."},{"key":"2026030916214312600_bib75","unstructured":"U.S. Department of Health and Human Resources\n          . Menstrual Hygiene Product Affordability and Accessibility for U.S. Individuals. Published online December 14, 2022. Accessed 1 September 2025. https:\/\/www.govinfo.gov\/content\/pkg\/CMRHE20_ 41-00185727\/pdf\/CMR-HE20_41-00185727.pdf."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/5\/1508\/2505475\/blooda_adv-2025-018315-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/5\/1508\/2505475\/blooda_adv-2025-018315-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:21:56Z","timestamp":1773087716000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/5\/1508\/565895\/Cost-effectiveness-of-first-line-IV-vs-oral-iron"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018315","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,10]]},"published":{"date-parts":[[2026,2,25]]}}}